RecruitingNot applicableNCT03838445

Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)

Studying Heritable pulmonary arterial hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
V-Wave Ltd
Principal Investigator
Victor Tapson, M.D.
Cedars-Sinai Medical Center
Intervention
V-Wave Interatrial Shunt(device)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
20202031

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03838445 on ClinicalTrials.gov

Other trials for Heritable pulmonary arterial hypertension

Additional recruiting or active studies for the same condition.

See all trials for Heritable pulmonary arterial hypertension

← Back to all trials